Diagnostic Accuracy and Clinical Significance of IGF-1 and C-Peptide as Biomarkers for Insulin Resistance in Weight-Stable Obese Patients: A Comparative ROC Curve Analysis

Journal of Analytical Science and Technology · Springer Nature · 2026-06-01 · DOI: 10.1134/S1990750826600330

Аннотация

Abstract Insulin resistance (IR) is a critical metabolic hallmark of obesity that may significantly hinder weight loss, leading to a phenomenon of “weight stability.” This study aims to investigate the association between insulin resistance and weight stability in obese patients and to evaluate the clinical utility of IR-related biomarkers (insulin, HOMA-IR, C-peptide, and IGF-1) as predictive indicators of the body’s metabolic response to weight-loss interventions. A case-control study was conducted involving 80 participants: 40 obese patients (20 males, 20 females) and 40 healthy controls (20 males, 20 females), to ensure sufficient power to detect statistically significant differences whilst improving the robustness and reliability of the results. Furthermore, the sample size was considered appropriate in comparison with similar studies reported in the literature. Biomarkers were measured using chemiluminescence immunoassay (CLIA) on the Mindray CL-1000i system. Diagnostic performance, including sensitivity, specificity, and optimal cut-off values, was determined using receiver operating characteristic (ROC) curve analysis. Significant elevations ( P < 0.001) in insulin, HOMA-IR, C-peptide, and IGF-1 were observed in obese patients compared to controls. ROC analysis demonstrated exceptional diagnostic accuracy for HOMA-IR and IGF-1, with an area under the curve (AUC) reaching 1.00 and 0.99, respectively, in female patients. Optimal cut-off values were established (e.g., 1.78 for HOMA-IR in males) to distinguish IR cases. Notably, while T.G. showed moderate diagnostic value, HDL exhibited poor sensitivity as a standalone marker. IGF-1 and HOMA-IR serve as highly precise biomarkers for identifying insulin resistance in obese individuals with weight stability. These findings suggest that metabolic profiling via CLIA technology can enhance early diagnosis and provide a biochemical explanation for the difficulty of weight loss, supporting personalized therapeutic strategies.

Читать у издателя →

Похожие статьи